New psoriasis drug enters Mid-Stage testing
NCT ID NCT07158268
Summary
This study aims to test if an investigational drug called HSK47388 is effective and safe for treating moderate to severe plaque psoriasis. It will involve about 220 adults with significant skin coverage and compare the drug against a placebo over 16 weeks. The main goal is to see if the drug can significantly clear skin lesions and improve patients' quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.